James Charles Miller - 17 Nov 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Director
Signature
By: Ryan D. Lake, attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Nov 2021
Net transactions value
+$1,689
Form type
4
Filing time
19 Nov 2021, 16:15:55 UTC
Previous filing
17 May 2021
Next filing
22 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $1,689 +1,000 +3.7% $1.69 27,923 17 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.